Christopher Harding is a corporate partner in the San Francisco office of Gibson, Dunn & Crutcher.  His practice is principally focused in private equity; mergers and acquisitions; and leveraged acquisitions.

Representative Matters:

GI Partners in various acquisitions and sales, including:

• acquisition of Insurity, Inc.
• strategic investment in Access Holdings
• acquisition of Doxim, Inc.
• acquisition of Togetherwork
• recapitalizations of MRI Software with TA Associates and Harvest Partners

Swander Pace in various acquisitions and sales, including:

• acquisition of Aden + Anais
• acquisition of Bragg Live Food Products
• acquisition of Café Valley
• acquisition of Captek Softgel
• acquisition of Functional Formularies
• acquisition of J&D Laboratories
• acquisition of J.R. Watkins
• acquisition of Passport Food Group

Vista Equity Partners in various acquisitions and sales, including:

• $1.55 billion acquisition of The Advisory Board Company’s education business, EAB
• take private acquisition of Cvent
• acquisition of Datto
• $1.6 billion acquisition of Infoblox
• $1.79 billion acquisition of Marketo
• C$4.8 billion combination of Misys with Canada-based financial technology firm DH Corporation (now Finastra Group)
• acquisition of Ping Identity
• acquisition of Superion
• acquisition of TIBCO Software Inc.in an all-cash transaction of $4.3 billion
• sale of TransFirst Inc.
• $2.7 billion acquisition of Vertafore
• $564 million acquisition of Xactly

Mr. Harding earned his Juris Doctor from University of Virginia School of Law and his Bachelor of Arts in History, summa cum laude, from the University of California, Los Angeles.  Prior to joining Gibson Dunn, Mr. Harding was a partner of Kirkland & Ellis and his representative transactions include those he led there.

He is admitted to practice in California and Oregon (inactive).